Trials / Completed
CompletedNCT01452412
Alkali Therapy in Chronic Kidney Disease
Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Albert Einstein College of Medicine · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Kidney disease is a common medical condition. Individuals with kidney disease develop a build-up of acid in their blood. This acid can affect their muscles, bones, glucose metabolism and kidneys. The investigators will test alkali treatment, to treat acid build-up, in a randomized placebo-controlled clinical trial to evaluate effects on muscles, bones, glucose metabolism and kidney.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium bicarbonate | 0.4 mEq/kg/day ideal body weight to be taken once a day |
| DRUG | Placebo | To be taken on the same schedule as the active arm |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2011-10-14
- Last updated
- 2020-01-07
- Results posted
- 2020-01-07
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01452412. Inclusion in this directory is not an endorsement.